Mobile Site ›

Thrombophilia


May 2013

An estimated 37 million patients are affected by thrombotic disorders each year. This number continues to rise as our aging population increases. For some patients, acquired risk factors, such as surgery or major trauma, may help explain the thrombotic event. When an acquired risk factor cannot be identified or when clinical and family history warrant, thrombophilia testing is recommended.

A full thrombophilia assessment measures:

  • Antithrombin
  • Protein C
  • Protein S
  • Activated protein C resistance
  • Lupus-like anticoagulant testing
  • Antiphospholipid antibodies
  • Genetic testing for the prothrombin G20210A and factor V Leiden (if appropriate)

Featured Algorithm

Featured Tests


Key